Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS ( R)), with commercial lipid-based formulations

Author： Fukui H.   Koike T.   Nakagawa T.   Saheki A.   Sonoke S.   Tomii Y.   Seki J.  

Publisher： Elsevier

ISSN： 0378-5173

Source： International Journal of Pharmaceutics, Vol.267, Iss.1, 2003-11, pp. : 101-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The lipid formulations of amphotericin B

By Herbrecht Raoul   Natarajan-Amé Shanti   Nivoix Yasmine   Letscher-Bru Valérie  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1277-1287

Informa Healthcare

Access to resources Recommend Favorite

Guidelines for lipid-based amphotericin B in SCT

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 306, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Guidelines for lipid-based amphotericin B in SCT

By  

Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats

By Ibrahim Fady   Gershkovich Pavel   Sivak Olena   Wasan Ellen K.   Wasan Kishor M.  

Drug Development and Industrial Pharmacy, Vol. 39, Iss. 9, 2013-09 ,pp. : 1277-1283

Informa Healthcare

Access to resources Recommend Favorite

Assessing the Antifungal Activity of a New Oral Lipid-Based Amphotericin B Formulation Following Administration to Rats Infected with Aspergillus Fumigatus

By Risovic Verica   Rosland Mike   Sivak Olena   Wasan Kishor M.   Bartlett Karen  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 7, 2007-07 ,pp. : 703-707

Informa Healthcare

Access to resources Recommend Favorite